Richard A. Miller - 31 Dec 2025 SCHEDULE 13G/A Report for Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS)

Filing Manager: Richard A. Miller
Reporting Manager: Richard A. Miller
Security: Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol: CRVS
Shares outstanding: 78,024,641 shares
Disclosed Ownership: 6,085,922 shares
Ownership: 7.8%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2026, 16:31:01 UTC
Date of event: 31 Dec 2025
Previous filing: 13 Feb 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
Richard A. Miller	7.8%	6,085,922	4,897,819	1,188,103	/s/ Richard A. Miller	Richard A. Miller
Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985	1.6%	1,188,103	0	1,188,103	/s/ Richard A. Miller	Richard A. Miller, Trustee
Sandra J. Horning	1.6%	1,188,103	0	1,188,103	/s/ Richard A. Miller	Richard A. Miller, Authorized Signatory